TRIMETHOPRIM-SULFAMETHOXAZOLE-RESISTANT PNEUMOCOCCAL DISEASE IN A PEDIATRIC ACQUIRED-IMMUNODEFICIENCY-SYNDROME PATIENT RECEIVING TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS

被引:6
作者
SLOBOD, KS
LEGGIADRO, RJ
机构
[1] LEBONHEUR CHILDRENS HOSP & MED CTR, DEPT INFECT DIS, MEMPHIS, TN 38103 USA
[2] ST JUDE CHILDRENS RES HOSP, MEMPHIS, TN USA
[3] UNIV TENNESSEE, MEMPHIS, TN USA
关键词
TRIMETHOPRIM-SULFAMETHOXAZOLE; PNEUMOCOCCUS; HUMAN IMMUNODEFICIENCY VIRUS;
D O I
10.1097/00006454-199405000-00023
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:423 / 424
页数:2
相关论文
共 50 条
[31]   CEFTIBUTEN AND TRIMETHOPRIM-SULFAMETHOXAZOLE FOR TREATMENT OF SHIGELLA AND ENTEROINVASIVE ESCHERICHIA-COLI DISEASE [J].
PRADO, D ;
LOPEZ, E ;
LIU, H ;
DEVOTO, S ;
WOLOJ, M ;
CONTRINI, M ;
MURRAY, BE ;
GOMEZ, H ;
CLEARY, TG .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1992, 11 (08) :644-647
[32]   POTENTIAL ROLE OF TRIMETHOPRIM-SULFAMETHOXAZOLE IN THE TREATMENT OF PEDIATRIC MYCOBACTERIUM-AVIUM COMPLEX INFECTIONS [J].
RASZKA, WV ;
SKILLMAN, LP ;
MCEVOY, PL .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (05) :418-419
[33]   SUCCESSFUL TRIMETHOPRIM SULFAMETHOXAZOLE THERAPY IN A PATIENT WITH HYPERIMMUNOGLOBULIN-E SYNDROME [J].
HATTORI, K ;
HASUI, M ;
MASUDA, K ;
MASUDA, M ;
OGINO, H ;
KOBAYASHI, Y .
ACTA PAEDIATRICA, 1993, 82 (03) :324-326
[34]   Neuropsychiatric Adverse Effects of Trimethoprim-Sulfamethoxazole: A Rare Case of Acute Psychosis in an Immunocompetent Patient [J].
Omri, Moujib ;
Ferhi, Mohamed ;
Mannai, Jihenne ;
Ben Salah, Khalil .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (09)
[35]   Transient psychosis in an immune-competent patient after oral trimethoprim-sulfamethoxazole administration [J].
Saidinejad, M ;
Ewald, MB ;
Shannon, MW .
PEDIATRICS, 2005, 115 (06) :E739-E741
[36]   A dose-escalation regimen of trimethoprim-sulfamethoxazole is tolerable for prophylaxis against Pneumocystis jiroveci pneumonia in rheumatic diseases [J].
Takenaka, Kenchi ;
Komiya, Yoji ;
Ota, Mineto ;
Yamazaki, Hayato ;
Nagasaka, Kenji .
MODERN RHEUMATOLOGY, 2013, 23 (04) :752-758
[37]   Twice weekly prophylaxis with trimethoprim/sulfamethoxazole for Pneumocystis jirovecii pneumonia in pediatric oncology patients [J].
Awad, Monica ;
Sierra, Caroline M. ;
Mesghali, Elhaam ;
Bahjri, Khaled .
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (08) :1936-1939
[38]   Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus [J].
Grim, SA ;
Rapp, RP ;
Martin, CA ;
Evans, ME .
PHARMACOTHERAPY, 2005, 25 (02) :253-264
[39]   Comparison of trimethoprim-sulfamethoxazole and aerosolized pentamidine for primary prophylaxis of Pneumocystis jiroveci pneumonia in immunocompromised patients with connective tissue disease [J].
Kimura, Miho ;
Tanaka, Sumiaki ;
Ishikawa, Akira ;
Endo, Hirahito ;
Hirohata, Shunsei ;
Kondo, Hirobumi .
RHEUMATOLOGY INTERNATIONAL, 2008, 28 (07) :673-676
[40]   TRIMETHOPRIM-SULFAMETHOXAZOLE OR CLINDAMYCIN FOR TREATMENT OF COMMUNITY-ACQUIRED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS SKIN AND SOFT TISSUE INFECTIONS [J].
Hyun, David Y. ;
Mason, Edward O. ;
Forbes, Andrea ;
Kaplan, Sheldon L. .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (01) :57-59